| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |